Stable signs of recovery also in the pharmaceutical industry. At least this is the photograph taken by the Pharmintec Observatory, which presented its fourth Report yesterday in Milan. Conducted on a sample of 113 companies - for a total of 11,000 employees and 3 billion in turnover - the survey provides encouraging data for the sector, which produces components, services, machinery and semi-finished products. Any examples? The 44% of the companies recorded a growth in turnover in the second half of 2010, the 33% approximately speaks of a stable market and only a fifth reports a drop in the income statement. Similar orientations with regard to exports: a third of the companies report increases, just over half point the needle of the barometer to "stable" and approximately 17% registers retreats. But the signs of greater optimism come from the expectations of the producers on the near future: the 52% of the companies expects an increase in turnover for the first half of 2011, while the 40% is in favor of a stable economic situation; the same goes for exports: the 40% of the sample expects an increase in orders from abroad while the 50% assumes a stable trend. As for employment, about three-quarters of companies expect unchanged jobs in the first half of this year, and 20% assumes new hires.
DoctorNews – June 1, 2011
